Ganga Pharmaceuticals Ltd.

View in App
10.80 -1.20 ▼-10.0%

28 September 2023, 04:01:00 PM
Volume: 8,000

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ayurvedganga.com
Market Cap 4.39 Cr.
Enterprise Value(EV) 6.18 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 0.10 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 111.59 Trailing Twelve Months Ending 2023-03
Industry PE 37.52 Trailing Twelve Months Ending 2023-03
Book Value / Share 13.42 Trailing Twelve Months Ending 2023-03
Price to Book Value 0.80 Calculated using Price: 10.80
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.41 Cr. 4,061,500 Shares
FaceValue 10
About Ganga Pharmaceuticals Ltd.
The company is a producer of quality bulk ayurvedic medicines in Mumbai. Apart from manufacturing, the company is also into marketing, distribution of Bulk Ayurvedic Medicines. Its product includes Ampachan Vati; Khadira Vati; Nirmalaya churna etc. Its products are available in liquid dosage form and solid dosage forms.

Ganga Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Ganga Pharmaceuticals Ltd. Performance

View details >>
1 Day
-10.00%
1 Week
-39.50%
1 Month
+0.93%
3 Month
+3.85%
6 Month
-22.47%
1 Year
+11.34%
2 Year
+116.00%
5 Year
+70.62%
10 Year

Ganga Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 1.28 1.36 1.57 1.91 3.70 3.59 0.38 0.70 0.72
Return on Capital Employed (%) 8.03 6.88 6.15 5.83 7.26 7.18 3.36 3.41 3.38
Return on Assets (%) 0.64 0.77 0.99 1.19 2.34 2.46 0.27 0.48 0.49

Ganga Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 3 3 5 5 5 5 5 5 5 5
Non Curr. Liab. 1 2 1 1 1 1 1 1 1 1
Curr. Liab. 1 1 1 2 2 2 2 2 2 2
Minority Int.
Equity & Liab. 5 5 7 8 8 8 8 8 8 8
Non Curr. Assets 3 3 3 3 4 3 3 3 3 3
Curr. Assets 2 2 5 4 5 4 4 5 5 5
Misc. Exp. not W/O 0
Total Assets 5 5 7 8 8 8 8 8 8 8

Ganga Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 3 3 3 3 3 3 3 2 2 3
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 3 3 3 3 3 4 3 3 3 3
Total Expenditure -2 -2 -2 -3 -3 -3 -3 -2 -2 -3
PBIDT 0 0 0 0 0 1 1 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 0 0 0

Ganga Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -1 0 0 0 0 0 0 0
Cash Fr. Inv. 0 0 -1 1 0 0 0 0 0 0
Cash Fr. Finan. 0 0 2 0 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 1 0 0 0 0 0 0

Ganga Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2023-03 (%)
Promoter 66.71 66.71 66.71 66.71 66.71 66.71 66.71 66.71 66.71
Public 33.29 33.29 33.29 33.29 33.29 33.29 33.29 33.29 33.29
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Ganga Pharmaceuticals Ltd. Announcements

View details >>
Sat, 16 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizers Report of voting at 34th AGM of the Company held on Saturday September 16 2023.
Sat, 16 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceeding and Voting Result of the 34th Annual General Meeting(AGM) of Ganga Pharmaceuticals Limited held on Saturday September 16 2023.
Wed, 23 Aug 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 read with Regulation 30 of the SEBI LODR Regulation 2015 we are enclosing herewith a copy of Notice in connection with the 34th Annual General Meeting published in the newspaper viz Financial Express (English) and Pratahkal (Marathi) newspaper on August 23 2023

Ganga Pharmaceuticals Ltd. Technical Scans

View details >>
Thu, 28 Sep 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Week Low Close Crossing Last Week Low
Opening at High Opening at High
Opening at Low Opening at Low
Closing Below Previous Low Closing Below Previous Low

Ganga Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 271,640.71 1,137.55 -0.2%
Divi's Laboratories Ltd. 97,263.71 3,663.85 -2.7%
Cipla Ltd. 93,971.75 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. 90,489.91 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. 72,268.33 5,026.15 -1.5%
Mankind Pharma Ltd. 70,687.84 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. 63,140.38 1,858.55 +0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.36 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-06 65.84 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-06 30.20 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.16 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.09 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 55.14 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.92 1,858.55 +0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.71 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-06 7.41 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-06 3.86 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.69 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.52 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 5.77 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.57 1,858.55 +0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,858.55 +0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,858.55 +0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,858.55 +0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,858.55 +0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,137.55 -0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,663.85 -2.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,164.00 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,425.55 -1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,026.15 -1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,764.60 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,858.55 +0.5%

Ganga Pharmaceuticals Ltd. FAQ's

What is Ganga Pharma. share price?
Can I buy Ganga Pharma. shares now?
What is the Market Cap of Ganga Pharma.?
What are the key metrics to analyse Ganga Pharma.?
What is the 52 Week High and Low of Ganga Pharma.?
What is the trend of Ganga Pharma. share price?